% JKM: adapted from Oxford Mathematical Institute
% Use one of the two documentclass lines depending on aspect ratio needed
% for 4x3 aspect ratio slides
% \documentclass{beamer}
% for 16x9 (modern wide screen) aspect ratio slides
\documentclass[aspectratio=169]{beamer}
\usetheme{uhcop}
%----------------------------------------
%          PACKAGES REQUIRED
%----------------------------------------

\usepackage{array}
\usepackage{booktabs}
\usepackage{tabularx}
\usepackage{array}
\usepackage{amsmath} 
\usepackage{xcolor}
\usepackage{ragged2e}
\usepackage{lmodern}


%----------------------------------------
%          BIBLIOGRAPHY STYLE
%----------------------------------------

%\usepackage[backend=biber,style=authoryear]{biblatex}
%\addbibresource{presentation_refs.bib} % your .bib file name here

%\RequirePackage[super,comma,numbers, sort&compress]{natbib}
\RequirePackage[authoryear,round,numbers,sort&compress]{natbib}
\bibliographystyle{unsrtnat}   % or abbrv, unsrt, alpha, unsrtnat, plainnat, etc.
\renewcommand{\bibnumfmt}[1]{[#1]}



%----------------------------------------
%          PERSONALIZE YOUR TALK 
%----------------------------------------

\title[My Talk]{Pharmacology of the PolC-type DNA polymerase III of the Human Gut Microbiome} 
\author{Jacob K. McPherson}
\institute{
Department of Pharmacological and Pharmaceutical Sciences\\
University of Houston
}
\date[\today]{\today} % [short]{long for title}

%----------------------------------------
%          CONSISTENT CHAPTER TITLES
%----------------------------------------

\newcommand{\chapterone}{%
Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in \textit{C. difficile} Infection
}

\newcommand{\chaptertwo}{%
Efficacy, safety, pharmacokinetics, and microbiome changes of ibezapolstat in adults with \textit{C. difficile} infection: a phase 2a multicenter clinical trial
}

\newcommand{\chapterthree}{%
The microbiome-restorative potential of ibezapolstat for the treatment of Clostridioides difficile infection...
}

\newcommand{\chapterfour}{%
Globally circulating \textit{C. difficile} are devoid of mutations associated with PolC inhibitor resistance
}

\newcommand{\chapterfive}{%

}

%----------------------------------------
%          INPUT SECTIONS OF CHAPTERS
%----------------------------------------

\begin{document}
\begin{frame}[plain]\titlepage\end{frame}
\section{Intro}
\input{presentation_intro}
\section{Ch.1}\input{presentation_ch1}
\section{Ch.2}\input{presentation_ch2}
\section{Ch.3}\input{presentation_ch3}
\section{Conclusion}
\input{presentation_conclusion}
\input{presentation_refs_acknowl}
\end{document}